Colorectal cancer Clinical Trials in Fairway, KS
As of June 2026, 3 paid clinical trials are recruiting for Colorectal cancer in Fairway, Kansas. Colorectal cancer trials explore novel chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Fairway
Filter results
3 clinical trials for Colorectal cancer
·Clear filters·↓ Download CSVA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
About research studies in Fairway
Fairway has approximately 88 recruiting research studies across a wide range of therapeutic areas. Kansas hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Fairway
Researchers run research studies in Fairway, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Clinical Research Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm | 32 |
| University of Kansas Medical Center | Amyotrophic Lateral Sclerosis, ASCVD, Alzheimer Disease | 9 |
| The University of Kansas Cancer Center | Advanced Breast Cancer, Advanced Solid Tumors With KRAS G12C Mutations, Aggressive B-Cell Non-Hodgkin Lymphoma | 6 |
| The University of Kansas Clinical Research Center | Acute Myeloid Leukemia, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer | 5 |
| University of Kansas | Acute Myeloid Leukemia (AML), Advanced Breast Cancer, Advanced Endometrial Carcinoma | 5 |
| University of Kansas Cancer Center | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML) | 4 |
| The University of Kansas Cancer Center (KUCC) | NSCLC Stage IV, Breast Cancer, Lung Cancer | 3 |
| The University of Kansas - Clinical Research Center | Amyloid, Cognitive Dysfunction, Lewy Body Disease | 2 |
| The University of Kansas Cancer Center, Investigational Drug Services | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 2 |
| A20 | Myasthaenia Gravis | 1 |
| Fairway North | Individual Stress and Weight Loss | 1 |
| GSK Investigational Site | Neoplasms, Solid Tumors | 1 |
| KU Clinical Research Center - Clinical and Translational Science Unit (CTSU) | Myositis | 1 |
| Kansas University Cancer Center | Advanced EGFR Positive Solid Tumor | 1 |
| Kansas University Clinical Research Center | Becker Muscular Dystrophy, Duchenne Muscular Dystrophy | 1 |
| Kansas University Medical Center | Acute Graft-versus-host Disease, Adverse Effects, Allogeneic Bone Marrow Transplantation | 1 |
| Local Institution - 0014 | Relapsed/Refractory Non-Hodgkin Lymphoma | 1 |
| Local Institution - 017-820J | Advanced NSCLC, Metastatic Lung Cancer | 1 |
| Nkarta Investigational Site | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis | 1 |
| The University of Kansas Cancer Center ,Investigational Drug Services | Acute Myeloid Leukemia, Myelodysplastic Syndrome | 1 |
| The University of Kansas Cancer Center Kucc University of Kansas Clinical Research Center | Myeloproliferative Neoplasms | 1 |
| The University of Kansas Hospital | Relapsed or Resistant Acute Leukaemias | 1 |
| The University of Kansas Medical Center Research Institute | AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent | 1 |
| University of Kansas Cancer Center Clinical Research Center (Fairway) | Solid Tumor | 1 |
| University of Kansas Hospital | Alzheimer's Disease | 1 |
Active & Upcoming Studies in Fairway (2026)
Recruiting trials in Fairway grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) · Phase 1, Phase 2 · Arsenal Biosciences, Inc.
- Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer · Phase 2 · University of Kansas Medical Center
Neurology & pain (4 active studies)
- Testing the Effects of a Text Message Caregiver Support Intervention for Latinos · University of Kansas Medical Center
- Alzheimer's Disease Neuroimaging Initiative 4 · University of Southern California
Vaccines (1 active study)
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study · Phase 3 · Ansun Biopharma, Inc.
Diabetes & metabolic (1 active study)
- Intensive Longitudinal Assessment of Stress and Stress-related Concepts Across a Behavioral Weight Loss Intervention · University of Kansas Medical Center
Pediatric (1 active study)
- Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · Phase 1 · National Cancer Institute (NCI)
Common conditions studied in Fairway
- Acute Myeloid Leukemia (9 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Stage IV Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Amyotrophic Lateral Sclerosis (3 active studies). Recruiting Amyotrophic Lateral Sclerosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Metastatic Malignant Solid Neoplasm (3 active studies). Recruiting Metastatic Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Myelodysplastic Syndrome (3 active studies). Recruiting Myelodysplastic Syndrome studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
Leading research sponsors in Fairway
- National Cancer Institute (NCI)
- University of Kansas Medical Center
- SWOG Cancer Research Network
- AstraZeneca
- Pfizer
Local regulations and guidelines
Clinical trials in Kansas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Kansas research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Fairway. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Fairway
Hipa.ai aggregates every recruiting study in Fairway from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Fairway?
There are approximately 88 recruiting clinical trials in Fairway, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fairway pay participants?
Most recruiting trials in Fairway compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fairway?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fairway?
The most common conditions under active study in Fairway include Acute Myeloid Leukemia (9), Stage IV Lung Cancer AJCC v8 (5), Amyotrophic Lateral Sclerosis (3), Metastatic Malignant Solid Neoplasm (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fairway?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fairway on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fairway?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fairway?
Recruiting research sites in Fairway include University of Kansas Clinical Research Center, University of Kansas Medical Center, The University of Kansas Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fairway right now?
The largest active categories in Fairway are Cancer & tumors (49), Neurology & pain (4), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.